Evaluation of factors influencing adherence to treatment with sodium-glucose cotransporter type 2 inhibitor

by D. A. Lebedev, A. A. Mosikian, A. Yu. Babenko
Published 2020-10-01

Decision modelling for the evaluation of diabetes outcomes

by A. A. Mosikian, W. Zhao, T. L. Galankin, A. S. Kolbin
Published 2017-11-01

Clinical Trials in Pediatrics and Neonatology: Reasons for Ups and Downs

by A. A. Mosikian, A. O. Tomasheva, T. L. Galankin, A. S. Kolbin
Published 2016-08-01

Evaluation of immunogenicity, efficacy and safety of GP40041 compared to Humulin® NPH in patients with type 2 diabetes mellitus

by A. G. Zalevskaya, A. A. Mosikian, O. V. Afonkina, R. V. Drai
Published 2019-08-01

Development and Validation of Approach for the Detection of Neutralizing Antibodies Against Insulin (Glargine) in Human Blood Plasma

by N. B. Abramenko, P. I. Vnukova, E. S. Golovina, I. E. Makarenko, A. A. Mosikian, A. G. Nikiforova, P. V. Gremyakova, V. I. Kazey
Published 2019-09-01